Caris Life Sciences, Inc.
CAI
$24.03
-$0.79-3.18%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -24.90% | -100.62% | 236.92% | 133.88% | 30.02% |
| Total Depreciation and Amortization | 29.08% | 18.04% | -11.89% | -24.01% | -9.03% |
| Total Amortization of Deferred Charges | -88.61% | 333.72% | -75.44% | -68.24% | 298.71% |
| Total Other Non-Cash Items | 179.45% | 2.27% | 2.06% | -74.86% | 35.60% |
| Change in Net Operating Assets | -418.19% | 114.02% | -519.51% | 1,078.94% | -110.80% |
| Cash from Operations | -13.38% | -26.58% | -28.27% | 756.55% | 123.26% |
| Capital Expenditure | -113.45% | -103.18% | 28.26% | -411.90% | 48.46% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1,081.51% | -103.18% | 28.26% | -411.90% | 48.46% |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | -1,015,772.50% | -2.56% | -69.57% | -4.55% | 0.00% |
| Issuance of Common Stock | 299.78% | -76.18% | 235.53% | -99.78% | 36,835.08% |
| Repurchase of Common Stock | -47,444.64% | 86.79% | 97.44% | -898.79% | -7,436.36% |
| Issuance of Preferred Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | -230.83% | 4,223.81% |
| Cash from Financing | -4,578.52% | -75.76% | 116.11% | -103.10% | 52,927.39% |
| Foreign Exchange rate Adjustments | -170.00% | 65.52% | -146.77% | -33.33% | 2,225.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -659.56% | -45.78% | 25.56% | -95.01% | 2,199.69% |